Palo Alto – December 19, 2014 – Cooley advised CardioKinetix, Inc. on its $50 million financing led by Edwards Lifesciences Corporation. CardioKinetix also entered into an agreement with Edwards Lifesciences that provides the company with the right to acquire CardioKinetix based on future regulatory milestones.
CardioKinetix is a medical device company pioneering a catheter-based treatment for heart failure.
The Cooley team advising CardioKinetix was led by partner Mark Weeks and included head of the mergers and acquisitions practice, Barbara Borden, and associates Justin Lau, Sepideh Mousakhani, James Allee and Jonathan Duckles.
Support was provided by partner Mark Windfeld-Hansen and associate Michael Baker (tax); partner Renee Deming (compensation and benefits); partner Francis Fryscak (antitrust); and partner Lila Hope (life sciences partnering).
About Cooley LLP
Cooley's attorneys solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and bet-the-company litigation, often where innovation meets the law.
Cooley has 800 lawyers across 11 offices in the United States and China.